Bio-Implants Market Size and Forecast (2021 – 2031)

Bio-Implants Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Cardiovascular Implants, Orthopedic Implants, Dental Implants, Ophthalmic Implants, and Others), Material (Metals, Ceramics, and Polymers), and End User (Hospitals & Clinics and Ambulatory Surgical Centers)

Send Enquiry



According to our new research study on “Bio-implants Market Forecast to 2031 – COVID-19 Impact and Global Analysis – by Type, Material, and End User,” the market is anticipated to grow from US$ 117.82 billion in 2023 to US$ 223.06 billion by 2031; it is estimated to register a CAGR of 8.3% during 2023–2031. Market growth is attributed to the increasing burden of lifestyle disorders and the growing demand for minimally invasive surgical procedures. Increasing technological developments and government initiatives will likely provide growth opportunities for the bio-implants market. However, product recalls and complexities associated with implant materials hinder the growth of the bio-implants market.

Bio-implants are prosthetic devices that replace, enhance, or support a biological structure. They consist of several biosynthetic components, such as tissue engineering products, along with collagen, including synthetic skin. Technological development in healthcare has contributed to the growth of the bio-implants market. Although the healthcare sector has made significant technological advancements over the years, the rising incidence of serious medical diseases has led to various challenges to the growth of the market for bio-implants.

North America accounted for the largest market share of the global bio-implants market in 2023. The market in this region is segmented into the US, Canada, and Mexico. The growth of the bio-implants market in the region is due to the growing prevalence of chronic diseases and better healthcare infrastructure. In July 2022, updated Centers for Disease Control and Prevention (CDC) data shows that coronary artery disease is one of the most common types of heart diseases, with approximately 20.1 million adults aged 20 and older living with the disease in the US. Additionally, according to CDC data, every 40 seconds, an individual suffers from a heart attack in the US, i.e., nearly 805,000 people. The rising incidence of chronic diseases is expected to increase the overall demand for bio-implants, which is expected to boost the market growth during the forecast period. Asia Pacific is expected to register the highest CAGR in the bio-implants market during 2023–2031. The market growth in the region is ascribed to the growing geriatric population, increasing disposable income, rising healthcare investments and expansion by market players, and increasing cases of spinal cord injuries due to the rising number of traffic accidents.

Increasing Technological Developments and Government Initiatives to Provide Market Opportunities in the Future

Technological developments such as 3D printing, laser technology, and nanotechnology have significantly improved the production of bio-implants. 3D printing has transformed the designing and manufacturing methodologies of bio-implants. This technology enables the creation of patient-specific implants with intricate geometries, precise dimensions, and tailored features, resulting in better fit and functionality. Further, integrating sensors, microelectronics, and wireless communication into implants helps in the real-time monitoring of the patient’s condition and health. Smart implants can transmit data to healthcare providers, enabling remote monitoring and timely interventions.

Many government organizations work with companies conducting health studies and producing medical devices to market new and more effective devices. For example, in December 2023, Nanyang Technological University Singapore and Singapore General Hospital (SGH) collaborated to invest in the advancement of 3D printing. The partnership leverages the facilities and combined expertise of the Singapore Center for 3D Printing at NTU and the 3D Printing Center at SGH to research and develop relevant technologies for clinical applications in point-of-care settings. In February 2024, a Pittsburgh engineer received US$ 557,000 from the National Institutes of Health to conduct the world’s first in vivo studies of orthopedic metamaterial implants to improve spinal injuries’ treatment, repair, and recovery. Metamaterials are more advanced than traditional elements, alloys, or other materials because they can be designed to provide a wide range of desired mechanical properties, including ultralight, ultra-stiff, ultrahigh strength-to-density ratios, compliance, and high resilience. In addition, metamaterial implants offer great scope for design as they can be made from various biocompatible materials. Thus, increasing technological developments and government initiatives are anticipated to provide growth opportunities for the market growth during the forecast period.

Type -Based Insights

Based on type, the bio-implants market is segmented into cardiovascular implants, orthopedic implants, dental implants, ophthalmic implants, and others. The cardiovascular implants segment held a larger market share in 2023. The growth of the segment is due to rapid rise in research and development activities to develop novel cardiac implant products. For example, in February 2022, Abbott, a medical technology company, announced the world’s first patient implantation of a leadless dual-chamber pacemaker system as part of its AVEIR DR i2i pivotal clinical trial. The implantation of Abbott’s experimental dual-chamber leadless pacemaker represents a significant technological milestone for leadless pacemaker technology; it is the first in the world to be in a pivotal trial.

Material-Based Insights

The bio-implants market, based on material, is segmented into metals, ceramics, and polymers. The metals segment held the largest bio-implants market share in 2023. It is further expected to register the highest CAGR from 2023 to 2031. The ceramics segment is expected to hold the second-largest market share during the forecast period due to increasing approvals of ceramic products by regulatory authorities. For example, in December 2021, DentalPoint, the pioneer of two-piece ceramic implants, announced that it had received US FDA approval for its newest product, ZERAMEX XT. The product is a metal-free alternative to titanium implants for cosmetic dentures, especially in the aesthetic area.

End User-Based Insights

Based on the end user, the market is bifurcated into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment held a larger bio-implants market share in 2023 and the same is anticipated to register a higher CAGR during 2023–2031.

Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquisition of a new customer base for tapping prevailing business opportunities.

• In April 2022, Orthopedic Implant Company received approval from the Food and Drug Administration and released the high valve dorsal scanning plate. The product helped expand the company’s orthopedic trauma portfolio for the potential clinical implantation of OIC’s DRPx Wrist Fracture Plating System, reinforcing it as one of the most comprehensive and value-driven alternatives to any other premium-priced plating systems.

• In January 2022, Johnson & Johnson Medical Devices Companies (JJMDC) collaborated with Microsoft to enhance and further develop JJMDC’s secure and compliant digital surgery ecosystem.

• In October 2021, ScottCare Cardiovascular Solutions signed an agreement with Ninety One Holding, Inc. to become the primary distributor for Ninety One’s cloud software platform for monitoring cardiac implanted devices, providing an effective expansion partnership between the two companies. This allows ScottCare Cardiocular Solutions to offer Ninety One’s cloud platform directly to clinics that work with their staff to monitor and manage patient data. Ninety One’s software platform helps in combining advanced data science with the latest technologies to help analyze and manage complex medical data for patients with implanted cardiac devices.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study, are among the primary and secondary sources referred to while preparing the bio-implants market report.

Summary Info


Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:




1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Bio Implants Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Bio Implants Market – Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Bio Implants Market – Global Market Analysis
6.1 Bio Implants – Global Market Overview
6.2 Bio Implants – Global Market and Forecast to 2031
7. Bio Implants Market – Revenue Analysis (USD Million) – By Type, 2021-2031
7.1 Overview
7.2 Cardiovascular Implants
7.3 Spinal Implants
7.4 Orthopedics Implants
7.5 Dental Implants
7.6 Ophthalmic Implants
7.7 Others
8. Bio Implants Market – Revenue Analysis (USD Million) – By Material, 2021-2031
8.1 Overview
8.2 Metal
8.3 Ceramics
8.4 Polymers
9. Bio Implants Market – Revenue Analysis (USD Million) – By End User, 2021-2031
9.1 Overview
9.2 Hospitals and Clinics
9.3 Ambulatory Surgical Centers
10. Bio Implants Market – Revenue Analysis (USD Million), 2021-2031 – Geographical Analysis
10.1 North America
10.1.1 North America Bio Implants Market Overview
10.1.2 North America Bio Implants Market Revenue and Forecasts to 2031
10.1.3 North America Bio Implants Market Revenue and Forecasts and Analysis – By Type
10.1.4 North America Bio Implants Market Revenue and Forecasts and Analysis – By Material
10.1.5 North America Bio Implants Market Revenue and Forecasts and Analysis – By End User
10.1.6 North America Bio Implants Market Revenue and Forecasts and Analysis – By Countries United States Bio Implants Market United States Bio Implants Market, by Type United States Bio Implants Market, by Material United States Bio Implants Market, by End User Canada Bio Implants Market Canada Bio Implants Market, by Type Canada Bio Implants Market, by Material Canada Bio Implants Market, by End User Mexico Bio Implants Market Mexico Bio Implants Market, by Type Mexico Bio Implants Market, by Material Mexico Bio Implants Market, by End User
Note – Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 Saudi Arabia
10.4.3 U.A.E
10.4.4 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. Industry Landscape
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. Bio Implants Market – Key Company Profiles
13.1 LifeNet Health
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note – Similar information would be provided for below list of companies

13.2 Smith & Nephew
13.3 Arthrex, Inc.
13.4 Clinic Lemanic
13.5 Alpha Bio Tec
13.6 MiMedx Group
13.7 Medtronic
13.8 St Jude Medical (Abbott)
13.9 Stryker Cooperation
13.10 DePuy Synthes
13.11 Biomet (Zimmer)
13.12 Exactech, Inc.
13.13 Cochlear Ltd
13.14 Straumann AG
14. Appendix
14.1 Glossary
14.2 About The Research Team
14.3 Market Intelligence Cloud



The List of Companies – Bio Implants Market

o LifeNet Health
o Smith & Nephew
o Arthrex, Inc.
o Clinic Lemanic
o Alpha Bio Tec
o MiMedx Group
o Medtronic
o St Jude Medical (Abbott)
o Stryker Cooperation
o DePuy Synthes
o Biomet (Zimmer)
o Exactech, Inc.
o Cochlear Ltd
o Straumann AG


There are no reviews yet.

Be the first to review “Bio-Implants Market Size and Forecast (2021 – 2031)”